Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |